Simvastatin and clarithromycin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Clarithromycin can increase simvastatin exposure and myopathy risk
Clarithromycin strongly inhibits CYP3A4 and can raise simvastatin concentrations. This increases myopathy and rhabdomyolysis risk, so the prescriber should review antibiotic or statin management. The other options either delay appropriate care, use an unsuitable medicine, or miss the main safety issue.
Reference: BNF